Literature DB >> 18565003

Detection of a characteristic painful neuropathy in Fabry disease: a pilot study.

Rainer Maag1, Andreas Binder, Christoph Maier, Andrea Scherens, Thomas Toelle, Rolf-Detlef Treede, Ralf Baron.   

Abstract

OBJECTIVE: Fabry disease (FD) is an X-linked lipid storage disorder showing a high prevalence and early occurrence of painful neuropathy. Early detection of this likely underdiagnosed disease is an important approach because a causal therapy is available.
DESIGN: We used a quantitative sensory testing to determine the detailed somatosensory profile of male Fabry patients and compare this profile with somatosensory profiles of other painful sensory neuropathies (SN).
RESULTS: Within this pilot-study, the profile revealed a small-fiber sensory neuropathy selectively affecting C- and A-delta fibers. The comparison with different somatosensory profiles of painful SN, including painful small-fiber sensory neuropathies of other etiologies, showed that the FD profile differs significantly and is characterized by a severe impairment of thermal and preserved vibratory and mechanical discrimination.
CONCLUSION: Thus, somatosensory profiling in male patients with painful extremities may be useful in the detection of FD.

Entities:  

Mesh:

Year:  2008        PMID: 18565003     DOI: 10.1111/j.1526-4637.2008.00470.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  14 in total

Review 1.  Fabry disease: a rare cause of neuropathic pain.

Authors:  Marieke Biegstraaten; Gabor E Linthorst; Ivo N van Schaik; Carla E M Hollak
Journal:  Curr Pain Headache Rep       Date:  2013-10

2.  FabryScan: a screening tool for early detection of Fabry disease.

Authors:  Kathrin Arning; Dennis Naleschinski; Rainer Maag; Marieke Biegstraaten; Peter Kropp; Jürgen Lorenzen; Carla E M Hollak; Ivo N van Schaik; Pontus Harten; Rainald A Zeuner; Andreas Binder; Ralf Baron
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

Review 3.  Neuropathic pain in children: Special considerations.

Authors:  Gary A Walco; Robert H Dworkin; Elliot J Krane; Alyssa A LeBel; Rolf-Detlef Treede
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

4.  [Procedure for certification of QST laboratories].

Authors:  C Geber; A Scherens; D Pfau; N Nestler; M Zenz; T Tölle; R Baron; R-D Treede; C Maier
Journal:  Schmerz       Date:  2009-02       Impact factor: 1.107

Review 5.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

Review 6.  Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.

Authors:  Alessandro P Burlina; Katherine B Sims; Juan M Politei; Gary J Bennett; Ralf Baron; Claudia Sommer; Anette Torvin Møller; Max J Hilz
Journal:  BMC Neurol       Date:  2011-05-27       Impact factor: 2.474

7.  Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A -10T genotype.

Authors:  Michael Schelleckes; Malte Lenders; Katrin Guske; Boris Schmitz; Christian Tanislav; Sonja Ständer; Dieter Metze; Istvan Katona; Joachim Weis; Stefan-Martin Brand; Thomas Duning; Eva Brand
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

Review 8.  Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring.

Authors:  Björn Hoffmann
Journal:  Orphanet J Rare Dis       Date:  2009-10-11       Impact factor: 4.123

9.  Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control study.

Authors:  Nurcan Üçeyler; Ann-Kathrin Kahn; Daniela Kramer; Daniel Zeller; Jordi Casanova-Molla; Christoph Wanner; Frank Weidemann; Zaza Katsarava; Claudia Sommer
Journal:  BMC Neurol       Date:  2013-05-24       Impact factor: 2.474

10.  Comprehensive and differential long-term characterization of the alpha-galactosidase A deficient mouse model of Fabry disease focusing on the sensory system and pain development.

Authors:  Nurcan Üçeyler; Lydia Biko; Dorothea Hose; Lukas Hofmann; Claudia Sommer
Journal:  Mol Pain       Date:  2016-05-04       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.